ALB and bacterial infectious disease: Moreover, recently published data from two RCTs on short-term (INFECIR-2 study of patients with non-SBP bacterial infections) and long-term (pilot PRECIOSA study of patients without infection) albumin treatment exhibited reductions of SI and circulatory dysfunction in patients with decompensated ACLD.